Reviewing Zynerba Pharmaceuticals Inc. (ZYNE)’s and INSYS Therapeutics Inc. (NASDAQ:INSY)’s results

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE) and INSYS Therapeutics Inc. (NASDAQ:INSY) compete against each other in the Biotechnology sector. We will compare them and contrast their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation.

Valuation and Earnings

Table 1 shows the top-line revenue, earnings per share (EPS) and valuation for Zynerba Pharmaceuticals Inc. and INSYS Therapeutics Inc.

Profitability

Table 2 has Zynerba Pharmaceuticals Inc. and INSYS Therapeutics Inc.’s net margins, return on assets and return on equity.

Risk Volatility

Zynerba Pharmaceuticals Inc.’s current beta is 4.93 and it happens to be 393.00% more volatile than Standard Poor’s 500. Competitively, INSYS Therapeutics Inc. is 156.00% more volatile than Standard Poor’s 500, because of the 2.56 beta.

Liquidity

Zynerba Pharmaceuticals Inc.’s Current Ratio is 8 while its Quick Ratio is 8. On the competitive side is, INSYS Therapeutics Inc.

... read more at: https://yomiblog.com/2019/03/10/reviewing-zynerba-pharmaceuticals-inc-zynes-and-insys-therapeutics-inc-nasdaqinsys-results/

Leave a Reply